Literature DB >> 18576290

Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises.

Phillip J Mease1, Lesley M Arnold, Leslie J Crofford, David A Williams, I Jon Russell, Louise Humphrey, Linda Abetz, Susan A Martin.   

Abstract

OBJECTIVE: In evaluating the effectiveness of fibromyalgia (FM) therapies, it is important to assess the impact of those therapies on the full array of domains considered important by both clinicians and patients. The objective of this research was to identify and prioritize the key clinically relevant and important domains impacted by FM that should be evaluated by outcome assessment instruments used in FM clinical trials, and to approach consensus among clinicians and patients on the priority of those domains to be assessed in clinical care and research.
METHODS: Group consensus was achieved using the Delphi method, a structured process of consensus building via questionnaires together with systematic and controlled opinion feedback. The Delphi exercises involved 23 clinicians with expertise in FM and 100 patients with FM as defined by American College of Rheumatology criteria.
RESULTS: The Delphi exercise revealed that the domains ranked most highly by patients were similar to the domain rankings by clinicians. Pain was consistently ranked highest by both panels. Fatigue, impact on sleep, health-related quality of life, comorbid depression, and cognitive difficulty were also ranked highly. Stiffness was ranked highly by patients but not clinicians. In contrast, side effects was important to clinicians but was not identified as important in the patient Delphi exercise.
CONCLUSION: The clinician and patient Delphi exercises identified and ranked key domains that need to be assessed in FM research. Based on these results, a conceptual framework for measuring patient-reported outcomes is proposed.

Entities:  

Mesh:

Year:  2008        PMID: 18576290     DOI: 10.1002/art.23826

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  86 in total

1.  Executive function in chronic pain patients and healthy controls: different cortical activation during response inhibition in fibromyalgia.

Authors:  Jennifer M Glass; David A Williams; Maria-Luisa Fernandez-Sanchez; Anson Kairys; Paloma Barjola; Mary M Heitzeg; Daniel J Clauw; Tobias Schmidt-Wilcke
Journal:  J Pain       Date:  2011-09-25       Impact factor: 5.820

2.  Development of responder definitions for fibromyalgia clinical trials.

Authors:  Lesley M Arnold; David A Williams; James I Hudson; Susan A Martin; Daniel J Clauw; Leslie J Crofford; Fujun Wang; Birol Emir; Chinglin Lai; Rong Zablocki; Philip J Mease
Journal:  Arthritis Rheum       Date:  2012-03

3.  Effects of exercise on physical limitations and fatigue in rheumatic diseases.

Authors:  Giuseppe Musumeci
Journal:  World J Orthop       Date:  2015-11-18

4.  QT dispersion and P wave dispersion in patients with fibromyalgia.

Authors:  Servet Yolbaş; Ahmet Yıldırım; Deccane Düzenci; Bülent Karakaya; Mustafa Necati Dağlı; Süleyman Serdar Koca
Journal:  Eur J Rheumatol       Date:  2016-12-01

5.  Applying area-under-the-curve analysis to enhance interpretation of response profiles: an application to sleep quality scores in patients with fibromyalgia.

Authors:  Andrew G Bushmakin; Joseph C Cappelleri; Gergana Zlateva; Alesia Sadosky
Journal:  Qual Life Res       Date:  2010-10-27       Impact factor: 4.147

Review 6.  Fibromyalgia: should the treatment paradigm be monotherapy or combination pharmacotherapy?

Authors:  Philip J Mease; Kristin Seymour
Journal:  Curr Pain Headache Rep       Date:  2008-12

7.  Advancing the screening of fibromyalgia in late-life depression: practical implications for psychiatric settings.

Authors:  John R Jochum; Amy E Begley; Mary Amanda Dew; Debra K Weiner; Jordan F Karp
Journal:  Int Psychogeriatr       Date:  2015-04-24       Impact factor: 3.878

Review 8.  [Cognitive impairment in patients suffering from fibromyalgia. An underestimated problem].

Authors:  T Schmidt-Wilcke; P Wood; R Lürding
Journal:  Schmerz       Date:  2010-02       Impact factor: 1.107

Review 9.  Understanding fibromyalgia: lessons from the broader pain research community.

Authors:  David A Williams; Daniel J Clauw
Journal:  J Pain       Date:  2009-08       Impact factor: 5.820

Review 10.  Advances in the assessment of fibromyalgia.

Authors:  David A Williams; Stephen Schilling
Journal:  Rheum Dis Clin North Am       Date:  2009-05       Impact factor: 2.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.